US1711262048
US1711262048
Pelthos Therapeutics Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 16.795.000 | -- | -- |
| Cost of Revenue | 9.365.000 | -- | -- |
| Gross Profit | 7.430.000 | -- | -- |
| 39.860.000 | 7.571.000 | 426.5% | |
| Operating Income | -32.430.000 | -7.571.000 | 328.3% |
| Pretax Income | -50.706.000 | -7.955.000 | 537.4% |
| Net Income Common Stockholders | -43.319.000 | -7.955.000 | 444.6% |
| -- | -- | -- | |
| -- | -- | -- |